Quick Overview
- A, D, E, and K are fat-soluble and require dietary fat and bile for absorption; A, D, and E store substantially in liver/adipose, whereas K stores are limited.
- Storage delays deficiency but increases toxicity risk. Terpenoids use 5-carbon isoprene units; C40 beta-carotene is a provitamin A tetraterpenoid.
Core Facts & Concepts
- A, D, E, K snapshot:
| Vitamin | Core role | Deficiency | Key numbers and toxicity |
|---|---|---|---|
| A | 11-cis-retinal for rhodopsin; retinoic acid supports epithelium | Night blindness, xerophthalmia, Bitot spots | RDA 700 micrograms RAE/day women; 900 men; preformed-retinol UL 3,000 micrograms/day; teratogenic/hepatotoxic |
| D | Calcitriol increases intestinal calcium/phosphate absorption and supports bone mineralization | Rickets, osteomalacia, hypocalcemia | RDA 15 micrograms/day (600 IU); 25-hydroxy D below 20 ng/mL indicates deficiency; excess causes hypercalcemia |
| E | Alpha-tocopherol: lipid-phase antioxidant protecting polyunsaturated membranes | Neuropathy, ataxia, hemolysis | RDA 15 mg/day; high doses increase bleeding risk |
| K | Cofactor for gamma-carboxylation of factors II, VII, IX, X, C, S | Bruising, bleeding, prolonged PT/INR | AI 90 micrograms/day women; 120 men; warfarin blocks recycling |
- Beta-carotene is cleaved to retinal then retinol; regulated conversion makes dietary carotenemia safer than preformed-retinol excess.
Problem-Solving Approach
- Check context: cholestasis, pancreatic insufficiency, chronic diarrhea, bariatric surgery, orlistat, bile-acid sequestrants, supplements, and warfarin.
- Localize clinically: night blindness/dry conjunctiva suggests A; bone pain/proximal weakness D; ataxia/hemolysis E; bleeding with prolonged PT/INR K.
- Confirm selectively: serum retinol below 20 micrograms/dL; 25-hydroxy D below 20 ng/mL with calcium/phosphate/ALP/PTH; lipid-adjusted alpha-tocopherol; PT/INR.
- Treat cause, then replete: monitor calcium during D therapy; avoid high-dose retinol in pregnancy or liver disease; investigate liver disease if PT/INR fails to correct with K.
⚠️ Warning: Visual loss, symptomatic hypocalcemia, hypercalcemia, major bleeding, or progressive ataxia require urgent assessment.
Analysis Framework
- Compare symptom-plus-laboratory patterns:
| Pattern | Likely clue |
|---|---|
| Ocular surface signs plus low retinol | A deficiency |
| Low 25-hydroxy D plus high ALP/PTH | D deficiency |
| Ataxia or hemolysis plus low alpha-tocopherol | E deficiency |
| Isolated prolonged PT/INR; factor VII falls early | K deficiency; distinguish liver disease |
- Multiple low vitamins imply fat malabsorption; isolated PT/INR elevation also warrants liver testing.
Visual Aid
Loading diagram…
Key Points Summary
- 🎯 A: vision and epithelium; preformed-retinol UL 3,000 micrograms/day.
- D: calcium/phosphate homeostasis; deficiency at 25-hydroxy D below 20 ng/mL.
- E: lipid-phase antioxidant; high doses can potentiate bleeding.
- K: gamma-carboxylates II, VII, IX, X, C, S; deficiency prolongs PT/INR; AI 90/120 micrograms/day.
- 🚩 Combined low levels suggest fat malabsorption; storage makes chronic overdose dangerous.
- Terpenoid pitfall: beta-carotene carotenemia yellows skin but not sclerae; it is not jaundice.
📌 Remember: A-D-E-K - Eyes, minerals, membranes, clotting.
⭐ Clinical Pearl: Measure 25-hydroxy D for stores; 1,25-dihydroxy D may remain normal early.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more